General
Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales
Danish pharmaceutical giant Novo Nordisk, known for its weight-loss drugs Wegovy and Ozempic, has named Maziar Mike Doustdar as its new chief executive, relying on an experienced company insider to make up ground lost to market rivals.
Mr Doustdar’s appointment came on Tuesday after the abrupt…
Continue Reading
-
General23 hours agoMagnitude-4.8 earthquake hits near Wyalkatchem in WA’s Wheatbelt, north-east of Perth
-
General20 hours ago‘Worrying’: fresh NAPLAN results trend revealed
-
Business19 hours ago3 common investor biases to watch this earnings season
-
Noosa News19 hours agoStar’s deal to sell Queen’s Wharf on verge of collapse a day before deadline